Evidence map›Paper›PMID 40860802›Full record

ArticleFrontiers in oncology2025

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review.

Pichayut Nithagon, Joeffrey Chahine, Lambros Stamatakis, Rashmi Samdani

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pichayut NithagonDepartment of Pathology and Laboratory Medicine, Medstar Georgetown University Hospital, Washington, DC, United States.
Joeffrey ChahineDepartment of Pathology and Laboratory Medicine, Medstar Georgetown University Hospital, Washington, DC, United States.
Lambros StamatakisMedstar Health Urology Oncology, Medstar Georgetown University Hospital, Washington, DC, United States.
Rashmi SamdaniDepartment of Pathology and Laboratory Medicine, Medstar Georgetown University Hospital, Washington, DC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary Renal Neoplasm with Reverse Polarity (PRNRP) is a rare renal tumor, recently described in 2019 by Al-Obaidy et al. defined by characteristic histology of papillary neoplasm with apically located WHO/ISUP grade 1nuclei and frequent

Indexed as

KRAS mutationmultiloculate cystic renal neoplasm of low malignancy potentialpapillary renal neoplasm with reverse polarityrenal neoplasm pathogenesissynchronous renal tumors

Identifiers

PMID40860802
PMCPMC12375447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.